AI Article Synopsis
- A case of congenital toxoplasmosis (TXP) is presented in a woman who had a Toxoplasma gondii infection over 6 months prior to conception and was treated with adalimumab for ankylosing spondylitis.
- Serology tests during her first trimester indicated prior infection, and an ultrasound at 26 weeks revealed cerebral lesions suggesting intrauterine infection.
- Following amniocentesis confirming TXP, the pregnancy was terminated at the parents' request, and the diagnosis was validated through fetal autopsy, highlighting concerns about immunosuppressive treatments like adalimumab and the necessity of preconception counseling.
Article Abstract
We present a case of congenital toxoplasmosis (TXP) in a woman with Toxoplasma gondii infection more than 6 months before conception. The woman has been treated with adalimumab for ankylosing spondylitis for 4 years until 5 months before conception. TXP serology at the first trimester was compatible with infection prior pregnancy. An ultrasound performed at 26 weeks gestation (WG) showed cerebral echogenic lesions compatible with intrauterine infection. Amniocentesis was performed which confirmed TXP fetal infection. Termination of the pregnancy was performed upon parent's requests and the fetal autopsy confirmed the diagnosis. Here, we discuss the potential role of immunosuppressive treatments, such as adalimumab, in the risk of congenital toxoplasmosis and the importance of counseling before pregnancy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292430 | PMC |
| http://dx.doi.org/10.1111/jog.14973 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!